5.15
Cara Therapeutics Inc Stock (CARA) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
28.93%
2.135
|
3.004 | 4.866 | 6.933 | 6.165 |
|
10.70%
31.80
|
35.61 | 33.76 | 39.27 | 33.81 |
Benefits Costs and Expenses |
7.10%
32.83
|
35.34 | - | - | 32.83 |
Costs And Expenses |
7.10%
32.83
|
35.34 | 33.76 | 39.27 | 32.83 |
Operating Income/Loss |
9.02%
-29.67
|
-32.61 | -28.90 | -32.34 | -27.65 |
Income/Loss From Continuing Operations Before Tax |
5.07%
-30.70
|
-32.34 | 4.866 | -31.48 | -26.66 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
5.07%
-30.70
|
-32.34 | -28.03 | -31.48 | -26.66 |
|
5.07%
-30.70
|
-32.34 | -28.03 | -31.48 | -26.66 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
49,158%
54.59
|
0.1108 | 54.24 | 54.00 | 53.87 |
Diluted Average Shares |
49,158%
54.59
|
0.1108 | 54.24 | 54.00 | 53.87 |
Basic Earnings Per Share |
6.67%
-0.56
|
-0.60 | -0.52 | -0.58 | -0.49 |
Diluted Earnings Per Share |
6.67%
-0.56
|
-0.60 | -0.52 | -0.58 | -0.49 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):